ProQR Therapeutics (PRQR) Receivables Refunds (2020 - 2025)
ProQR Therapeutics recorded quarterly Receivables Refunds of $1.1 million in Q4 2025, up 44.14% quarter-over-quarter from $737330.8 in Q4 2024, and up 44.14% year-over-year from $737330.8 in Q4 2024.
ProQR Therapeutics' Receivables Refunds history runs 6 years deep, the most recent figure standing at $1.1 million for Q4 2025.
- In Q4 2025, Receivables Refunds rose 44.14% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $1.1 million (up 44.14% YoY), while the FY2025 annual figure was $1.1 million, up 44.14% from the prior year.
- Receivables Refunds came in at $1.1 million for Q4 2025 at ProQR Therapeutics, up from $737330.8 in the prior quarter.
- In the past five years, Receivables Refunds ranged from a high of $1.1 million in Q4 2025 to a low of $435569.8 in Q2 2023.
- A 5-year average of $657478.5 and a median of $598121.6 in 2023 frame the typical range for Receivables Refunds.
- Across the five-year window, Receivables Refunds sank 46.18% in 2023 and jumped 44.14% in 2025, its largest moves.
- ProQR Therapeutics' Receivables Refunds stood at $634903.9 in 2021, then slipped by 2.46% to $619290.2 in 2022, then fell by 6.84% to $576953.0 in 2023, then increased by 27.8% to $737330.8 in 2024, then jumped by 44.14% to $1.1 million in 2025.
- According to Business Quant data, Receivables Refunds over the past three periods registered $1.1 million, $737330.8, and $576953.0 for Q4 2025, Q4 2024, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | 1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 737,330.83 |
| Sep 30, 2023 | 576,952.95 |
| Jun 30, 2023 | 435,569.76 |
| Mar 31, 2023 | 490,517.21 |
| Dec 31, 2022 | 619,290.15 |
| Sep 30, 2022 | 574,716.37 |
| Jun 30, 2022 | 531,394.23 |
| Mar 31, 2022 | 911,338.23 |
| Dec 31, 2021 | 634,903.88 |
| Dec 31, 2020 | 501,954.03 |